Women with severe coronary heart disease causing narrowing or blockages in the arteries may derive greater long-term benefits ...

Find out about rising PCI rates after TAVR and what they mean for lifetime cardiac care. Learn more about the data.

Coronary artery disease (CAD) can reduce people’s life expectancy. However, this depends on various factors, including the severity of the condition, treatment efficacy, and whether the person has ...

The field of coronary artery disease saw its share of negative trials in 2024, but also got new guidelines, and a truce between interventionalists and surgeons. One long-awaited trial stood out: ...

A prospective, non-inferiority, randomised controlled TCW trial at 18 tertiary centres (2018-2023). Patients (n = 172) had severe aortic stenosis and complex coronary artery disease. They were ...

In patients with coronary artery disease (CAD) and obesity, tirzepatide was associated with lower mortality and reduced ...

Novo Nordisk ($NVO) announced an update on their ongoing clinical study. In a bid to address the persistent threat of coronary artery disease ...

A noninvasive AI tool may be able to predict potential cardiovascular events in patients with suspected stable coronary ...

SpectraWAVE makes technologies to help diagnose and guide treatment decisions for coronary artery disease.

Both overweight and obesity can increase the risk of developing coronary artery disease. Maintaining a healthy diet and a moderate weight can help decrease the chance of this and other heart ...

in Coronary Artery Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. Coronary Artery Disease pipeline report also covers the ...